Today: June 25, 2017, 5:36 pm
  
Health

AMPS LLC releases version 2 of FAT-QT, a tool for fully automated analysis of ECG traces

AMPS is proud to announce the official release of version 2 of FAT-QT (Fully Automatic Thorough-QT), which brings together the features of the company’s two successful and enhanced tools, CalECG v4 and the FDAEcg Suite v2, making it a single platform capable of performing a fully automated analysis of 12-lead ECGs.
AMPS LLC releases version 2 of FAT-QT, a tool for fully automated analysis of ECG traces
PR-Inside.com: 2017-06-15 16:36:53
AMPS is proud to announce the official release of version 2 of FAT-QT (Fully Automatic Thorough-QT), which brings together the features of the company’s two successful and enhanced tools, CalECG v4 and the FDAEcg Suite v2, making it a single platform capable of performing a fully automated analysis of 12-lead ECGs.

FAT-QT v2 combines the advantages of a much-improved measurement algorithm of CalECG v4, as well as the enhanced filters developed for our AMPS FDAEcg Suite scoring module, which empowers it with the capability for much faster analysis of ECG traces. This enhancement makes it especially useful in the context of Thorough-QT studies, and in clinical trials in general, via pre-processing, measuring, and sorting of all the ECG traces in different quality sets.


With FAT-QT v2, ECGs are at first automatically annotated with the improved algorithm of CalECGv4 and then, using different Scoring Metrics, they are classified into different quality categories. Both the Scoring Metrics and the Number of Categories are user configurable. At the end of a FAT-QT session, the potentially needed expert review can be limited to the lower quality ECG subsets, thereby greatly reducing the time and the resources spent on manual review and analysis of ECGs for each study. FAT-QT v2 therefore enables users with reliable, faster, and cheaper processing of large numbers of ECG traces.

This new version (v2) of FAT-QT offers some major enhancements:

• Inclusion of the latest version of BRAVO measuring algorithm

• Full management of JTp/TpTe interval annotations

• Inclusion of FDA Public Library open Source Codes (ECGLib)

• Addition of following new scoring metrics:
o JTp interval measured by the algorithm. Global JTp on Representative Beats (superimposed) generated by AMPS
o T-wave area-based parameters
o Parameters from Gaussian Mesa Functions modeling of the T wave on PC1 lead
o T-wave complexity can now be assessed on all leads
o T-wave amplitude can now be assessed on all leads

• Compatibility with Windows Server 2016 Operating System

Fabio Badilini, PhD, FACC, Chief Scientist and AMPS founder commented: “These last few months have been very exciting as we made major steps forward in several of our products, and developed new ones to answer the needs of the market, which led to the set of announcements made today. He also added: “I am particularly proud both for the result we achieved and of the AMPS team of engineers that helped in achieving such a major leap forward for our customers”.

About AMPS LLC: Based in New York (NY), AMPS LLC is a dynamic software company providing cutting-edge software solutions for key applications like Quantitative ECG Analysis and Blood Pressure Monitoring that are critical measurements for Clinical Research Organizations and Pharmaceutical companies. AMPS LLC is well known for the support it has been extending to the FDA in establishing the HL7 XML ECG standards, and for providing its famous AMPS XMLFDA Viewer tool to the FDA.

The company’s website is www.amps-llc.com. For more information, please contact:

AMPS, LLC

418 Central Park West

New York, NY, 10025

For pricing propositions: marketing@amps-llc.com

For technical questions: support@amps-llc.com

Press Information
AMPS LLC
418 Central Park West

Daniel Bovio
VP Marketing & Sales
2127494076
email
www.amps-llc.com


# 561 Words
Related Articles
More From The Author
AMPS LLC releases version 4 of the [..]
AMPS is pleased to announce the release of version 4 of CalECG, our popular application for on-screen measurement of ECG [..]
 
More From Health
PromarkerD can predict Diabetic Kidney Disease better [..]
- PromarkerD predicted 86% of disease-free patients who went on to develop chronic kidney disease within four years - Largest [..]
Human Heart Tissue Grown from Stem Cells [..]
SINGAPORE, June 8, 2017 - (ACN Newswire) - Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have [..]
Cannabidiol (CBD) Oil Rated as "A Game [..]
While there is still a lot of research to be done, we have already gotten some pretty promising results about [..]
Global and Chinese 5-Aminosalicylic acid Industry Market [..]
HTF Market Intelligence released a new research report of 150 pages on title 'Global and Chinese 5-Aminosalicylic acid (CAS 89-57-6) [..]
New Silkroutes Group to Acquire Dental Businesses [..]
Expected to be completed by 31 July 2017, acquisitions will bolster capabilities of NSG's 51%-owned healthcare practice group, [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.